SPL 2.11% 9.3¢ starpharma holdings limited

Starpharma's Radiotherapeutics and Telix's Molecularly Targeted Radiation platform, page-6

  1. 321 Posts.
    lightbulb Created with Sketch. 84
    Many irons in the fire is useless if SPL not know how to run good quick clinical trial or get a drug registered. Telex have achieved much more in a few years than jacky has in 17. Chris B has shown what good management is and jacky could learn from him.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.